Akebia Therapeutics Inc logo

AKBA

Akebia Therapeutics Inc

$1.15

Earnings Summary

Revenue
$32.61Mn
Net Profits
$-17.99Mn
Net Profit Margins
-55.16%

Highlights

Revenue:

Akebia Therapeutics Inc’s revenue fell -18.74% since last year same period to $32.61Mn in the Q1 2024. On a quarterly growth basis, Akebia Therapeutics Inc has generated -41.98% fall in its revenue since last 3-months.

Net Profits:

Akebia Therapeutics Inc’s net profit fell -7.45% since last year same period to $-17.99Mn in the Q1 2024. On a quarterly growth basis, Akebia Therapeutics Inc has generated -3029.15% fall in its net profits since last 3-months.

Net Profit Margins:

Akebia Therapeutics Inc’s net profit margin fell -32.23% since last year same period to -55.16% in the Q1 2024. On a quarterly growth basis, Akebia Therapeutics Inc has generated -5148.2% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Akebia Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Year
-0.08

Highlights

EPS Estimate Current Year:

Akebia Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.08.

Key Ratios

Key ratios of the Akebia Therapeutics Inc post its Q1 2024 earnings

Earning Per Share (EPS)
-0.09
Return on Assets (ROA)
-0.08
Return on Equity (ROE)
-5.53

Highlights

Earning Per Share (EPS):

Akebia Therapeutics Inc’s earning per share (EPS) jumped 35.71% since last year same period to -0.09 in the Q1 2024. This indicates that the Akebia Therapeutics Inc has generated 35.71% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Akebia Therapeutics Inc’s return on assets (ROA) stands at -0.08.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Akebia Therapeutics Inc’s return on equity (ROE) stands at -5.53.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-09
-0.08
-0.09
-12.5%